Hanall Biopharma Co., Ltd. announced earnings results for the first half of fiscal year of 2014. For the period, the company has turned a profit of USD 0.72 million including operation profit of USD 0.64 million over the first half of fiscal year of 2014. The company turns a profit of USD 4 million operation losses and USD 3.4 million net loss of the first half of the fiscal year of 2013 by achieving USD 37 million in revenues over the first half of fiscal year of 2014.

This is estimated to be USD 3.1 million increase in revenue when compared that of the first half was USD 34 million in 2013. The company is able to turn a profit by increase in sales of selecting strategic products and business rationalization.